AstraZeneca PLC (AZN :)

LATEST ABOUT THIS TOPIC ON CNBC.COM

• More

• U.S. lawmaker would give FDA more oversight of drug compounding 23 hrs ago - Reuters
• Immune system cancer drugs tipped to be a $35 bln market 22 May 2013 - Reuters
• AstraZeneca closes in on site for new home in Cambridge 20 May 2013 - Reuters
• Impax Labs launches generic version of Zomig 17 May 2013 - The Associated Press
• UPDATE 1-Cubist bid for Optimer before sale process began-sources 15 May 2013 - Reuters
• RPT-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices 10 May 2013 - Reuters
• Drug Spending Drops for the First Time in 55 Years 09 May 2013 - Reuters
• European shares slip from multi-year highs 09 May 2013 - Reuters
• European shares dip from multi-year highs 09 May 2013 - Reuters
• U.S. spending on medicines fell for first time in 2012 08 May 2013 - Reuters

MORE FROM CNBC

• More

• Stocks End Off Highs, but S&P, Nasdaq Log Gains for 5th Day 25 Apr 2013 - CNBC.com
• Europe Closes Up on Upbeat UK GDP 25 Apr 2013 - CNBC.com
• Futures Edge Higher on Earnings, Jobless Claims; 3M Slumps 25 Apr 2013 - CNBC.com

MORE FROM OUR PARTNERS

• More

• Billionaire Jim Simons' Top Dividend Stock Holdings 5 hrs ago - Seeking Alpha
• AstraZeneca: A Dividend Payer With An Attractive Growth Prospect 20 May 2013 - Seeking Alpha
• Array Biopharma: Measuring The Strength Of This Small-Cap Pharma Stock 15 May 2013 - Seeking Alpha
• What To Buy And Sell In Your High-Yield Portfolio 14 May 2013 - Seeking Alpha
• Wall Street Breakfast: Must-Know News 14 May 2013 - Seeking Alpha
• Part 2: Will Array BioPharma Become A Late-Stage Biopharmaceutical Com... 12 May 2013 - Seeking Alpha
• Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Com... 12 May 2013 - Seeking Alpha
• 6 Superstars For Your Biotech Portfolio: John McCamant 10 May 2013 - Seeking Alpha
• Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Ar... 09 May 2013 - Seeking Alpha
• Pounding The Table On Pozen: Why There's Upside In This Misunderstood ... 08 May 2013 - Seeking Alpha

LATEST TRANSCRIPTS

• More

• AstraZeneca's CEO Discusses Q1 2013 Results - Earnings Call Transcript 26 Apr 2013 - Seeking Alpha

PRESS RELEASES

• More

• Actavis Confirms Appeals Court Issues Injunction Related to Generic Pu... 54 mins ago - PR Newswire
• Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan ... 9 hrs ago - PR Newswire
• SumTotal Named a "Champion" in McLean & Company's Talent Management Su... 23 May 2013 - Business Wire
• Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 23 May 2013 - PR Newswire
• Research and Markets: Metabolomics Market By Applications and Indicati... 22 May 2013 - Business Wire
• Par Pharmaceutical Begins Shipment of Generic Atacand?? 22 May 2013 - PR Newswire
• Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 22 May 2013 - PR Newswire
• Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 22 May 2013 - PR Newswire
• Industry Leader John Reynders Joins Moderna Therapeutics as Chief Info... 22 May 2013 - PR Newswire
• CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013 22 May 2013 - Business Wire

• 

  Yahoo Joins Growing List of Hulu Bidders

• Fixing Bridges and the Corporate Tax Issue
• More Evidence Banks Violated Mortgage Pact: NY AG
• Beware Postcards Promising Free Trips and Tickets
• Men Help Recharge US Luxury Buying
• Cut the Hassles of Summer Travel and Save Money
• How Motorsports Improves What We Drive
• P&G CEO Retiring Due to 'Distraction' of Critics
• British Police Arrest Two Men on Pakistan Flight
• Watching for Signs of a Too-Strong US Economy

• Download Free Annual Report.